Subscribe
shutterstock_1147238582_testing
Testing / Shutterstock.com
15 June 2020Asia-PacificSarah Morgan

Roche and Innovent unite in $2bn biospecifics deal

Swiss healthcare company  Roche has partnered with Chinese biotech  Innovent Biologics to develop cell therapies and bispecific antibodies.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Fed Circuit restores two Illumina DNA patents in blow to Roche
19 March 2020   The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.
Americas
Genentech in $1.7bn immuno-oncology deal
27 February 2020   California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.
Americas
Roche accuses competitor of infringing diabetes patent
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Fed Circuit restores two Illumina DNA patents in blow to Roche
19 March 2020   The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.
Americas
Genentech in $1.7bn immuno-oncology deal
27 February 2020   California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.
Americas
Roche accuses competitor of infringing diabetes patent
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.

More on this story

Americas
Fed Circuit restores two Illumina DNA patents in blow to Roche
19 March 2020   The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.
Americas
Genentech in $1.7bn immuno-oncology deal
27 February 2020   California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.
Americas
Roche accuses competitor of infringing diabetes patent
22 June 2020   Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool